Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles
Launched by MERZ AESTHETICS GMBH · Nov 22, 2019
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female between ≥18 and ≤65 years old.
- • Décolleté wrinkles with a rating of moderate to severe (grade 2 to 3) on the MAS Décolleté Wrinkles-At Rest as determined by the blinded live rater and confirmed by the treating investigator afterwards.
- Exclusion Criteria:
- • Any previous treatment with fat injections, poly L-lactic acid or permanent dermal fillers (e.g., silicone, polymethyl methacrylate) in the décolleté.
- • Any previous surgery, including plastic surgery, or surgical permanent implant in the décolleté or in the breasts that could interfere with effectiveness and safety.
- • Any previous thread lifting in the décolleté.
- • Previous treatment with collagen fillers, calcium hydroxylapatite (CaHa), and/or long-lasting hyaluronic acid (HA) fillers (e.g., Belotero® Intense/Volume, Juvéderm® Volift/Volbella) in the décolleté within the past 24 months before baseline.
- • Previous treatment with other HA fillers in the décolleté within the past 12 months before baseline.
- • Previous treatment with botulinum toxin, ablative or fractional laser, microdermabrasion, microneedling, chemical peels and/or non-invasive skin tightening (e.g., ultrasound, radiofrequency, intense pulsed light treatment) in the décolleté within the past 6 months before baseline.
About Merz Aesthetics Gmbh
Merz Aesthetics GmbH is a leading global provider of innovative aesthetic solutions, dedicated to enhancing the quality of life through advanced medical aesthetics products and services. As a subsidiary of Merz Group, the company focuses on developing cutting-edge treatments that address the needs of patients and practitioners in the aesthetics field. With a commitment to research and development, Merz Aesthetics GmbH conducts clinical trials to ensure the safety, efficacy, and quality of its offerings, striving to set new standards in the industry and contribute to the ongoing evolution of aesthetic medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamburg, , Germany
Hamburg, , Germany
Kassel, , Germany
Potsdam, , Germany
Bad Soden, , Germany
Drensteinfurt, , Germany
München, , Germany
München, , Germany
Wuppertal, , Germany
Patients applied
Trial Officials
Merz Medical Expert
Study Director
Merz North America, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials